Rigel Pharmaceuticals (RIGL) Selling, General & Administrative (2009 - 2026)
Rigel Pharmaceuticals' Selling, General & Administrative came in at $32.64 million for Q2 2026, up 11.6% from $29.26 million a year earlier and up 6.5% from the prior quarter.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) Selling, General & Administrative (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Rigel Pharmaceuticals reported Selling, General & Administrative of $122.22 million, up 7.7% year-over-year; for FY2025, it was $115.9 million, up 2.5% from FY2024.
- Selling, General & Administrative carries a five-year compound annual growth rate of 8.6% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $113.06 million in FY2024 (+6.9%), $105.74 million in FY2023 (-6.0%), $112.45 million in FY2022 (+22.4%) and $91.89 million in FY2021 (+20.0%).
- The Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to Q2 2010.
- Year-over-year, Selling, General & Administrative has increased for five consecutive quarters, with growth averaging 6.4% over the last eight quarters.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2021 (growth of 31.3%), and the weakest in Q4 2023 (a decline of 16.5%).
- Business Quant data shows RIGL's Selling, General & Administrative at $30.65 million (Q1 2026), $29.99 million (Q4 2025) and $28.94 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.28 Bn |
| 10 | Rigel Pharmaceuticals | 826.82 Mn | 330.55 Mn | 70.11 Mn | 34.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 34.73 Mn |
| Jun 30, 2026 | 32.64 Mn |
| Mar 31, 2026 | 30.65 Mn |
| Dec 31, 2025 | 29.99 Mn |
| Sep 30, 2025 | 28.94 Mn |
| Jun 30, 2025 | 29.26 Mn |
| Mar 31, 2025 | 27.72 Mn |
| Dec 31, 2024 | 29.52 Mn |
| Sep 30, 2024 | 27.04 Mn |
| Jun 30, 2024 | 28.05 Mn |
| Mar 31, 2024 | 28.45 Mn |
| Dec 31, 2023 | 26.85 Mn |
| Sep 30, 2023 | 24.86 Mn |
| Jun 30, 2023 | 26.31 Mn |
| Mar 31, 2023 | 27.73 Mn |
| Dec 31, 2022 | 32.17 Mn |
| Sep 30, 2022 | 25.90 Mn |
| Jun 30, 2022 | 26.98 Mn |
| Mar 31, 2022 | 27.40 Mn |
| Dec 31, 2021 | 24.52 Mn |
API Access
Rigel Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RIGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "RIGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RIGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();